7 Results for "

MDCKII-MDR1 cells

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "MDCKII-MDR1 cells" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-146148
CAS No.: 52348-60-4
Purity:  98.99%
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM4C-IN-1 is a histone lysine demethylase KDM4C inhibitor with an IC50 of 8 nM. KDM4C-IN-1 inhibits cancer cell proliferation. KDM4C-IN-1 can be used in the research of hepatocellular carcinoma and adenocarcinoma alveolar basal epithelial carcinoma .
loading...
    loading...
Cat. No.: HY-155351
CAS No.: 2819998-97-3
Purity:  98.22%
Target:  

PARP Cytochrome P450

Research Areas:  

Cancer

PARP7-IN-15 is an orally active and selective PARP7 inhibitor with an IC50 of 0.56 nM. PARP7-IN-15 inhibits the enzymatic activity of PARP7 and induces anti-tumor activity against lung cancer in vivo. PARP7-IN-15 can be used for the research of lung cancer .
loading...
    loading...
Cat. No.: HY-172826
Target:  

Bacterial

Research Areas:  

Infection

Anti-MRSA agent 26 is a potent anti-MRSA agent with MIC <0.015 μg/mL. Anti-MRSA agent 26 has superior activity against a broad range of Gram-positive pathogens and shows no cytotoxicity in three mammalian cell lines (Caco-2, DU-145 and MDCKII MDR1 cells) at 10 μM. Anti-MRSA agent 26 has a robust TAP pharmacophore and an excellent antibacterial activity in Staphylococcus aureus skin infection mice model .
loading...
    loading...
Cat. No.: HY-14300D
CAS No.: 503068-35-7
Synonyms: GW642444 acetate
Target:  

Adrenergic Receptor

Research Areas:  

Inflammation/Immunology

Vilanterol (GW642444) acetate is a long-acting β2 adrenergic receptor agonist. Vilanterol acetate has pEC50 values for β2-AR, β1-AR, and β3-AR of 9.4, 6.4, and 6.1, respectively. Vilanterol acetate selectively activates airway β2 adrenergic receptors, increases cAMP and thus relaxes bronchial smooth muscle. Vilanterol acetate can be used in asthma research [1][2].
loading...
    loading...
Cat. No.: HY-181636
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

VU6077967 is a selective cannabinoid receptor 2 (CB2) agonist with an EC50 of 8.6 nM for rCB2. VU6077967 can be used for the research of neurological disease, suah as Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-181559S
Synonyms: AG06827
Target:  

mAChR

Research Areas:  

Neurological Disease

VU6025733 (AG06827) is a highly selective, orally active and blood-brain barrier-penetrant positive allosteric modulator of the muscarinic acetylcholine receptor subtype M4 (M4 mAChR). VU6025733 exerts a potentiating effect on acetylcholine-induced receptor activation with an EC50 of 23 nM for hM4 and 55 nM for rM4. VU6025733 shows high selectivity over other muscarinic acetylcholine receptor subtypes, dose-dependently reduces amphetamine-induced hyperlocomotion in rats. VU6025733 is applicable to the research of schizophrenia, Parkinson's disease, and Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-187355
Target:  

mAChR

Research Areas:  

Neurological Disease

VU6077564 is a reversible competitive antagonist of M1 mAChR, with an IC50 of 31 nM in human (CHO cells) and 39.5 nM in rats. VU6077564 promotes axon growth of sensory neurons from adult rat dorsal root ganglia cultured in vitro. VU6077564 can be used for the research of peripheral neuropathy .
loading...
    loading...